Finlius 90 mg

FINLIUS 90 MG is a subcutaneous solution containing ustekinumab, used for managing moderate to severe plaque psoriasis. This medication helps reduce inflammation and improve skin condition.

FINLIUS 90 MG is primarily used for the treatment of moderate to severe plaque psoriasis in adults. It works by targeting specific proteins in the body to reduce inflammation and slow down the overproduction of skin cells. This helps to alleviate symptoms such as red, scaly patches and itching. The medication is administered via subcutaneous injection, making it a convenient option for long-term management of psoriasis.

Common effects of FINLIUS 90 MG may include redness, itching, or swelling at the injection site. Some individuals might experience headaches, fatigue, or mild upper respiratory infections. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

FINLIUS 90 MG should be used with caution in individuals with a history of infections or allergic reactions to ustekinumab. It is important to inform your healthcare provider about any current medications or health conditions before starting treatment. The medication should be stored properly to maintain its effectiveness.

FINLIUS 90 MG may interact with other medications, particularly those that affect the immune system. It is important to avoid alcohol while using this medication, as it can increase the risk of side effects. Always consult a healthcare provider before combining FINLIUS 90 MG with other treatments.